|
SkyePharma PLC - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for SkyePharma PLC Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
SkyePharma PLC. The Group's principal activity is researching and developing, manufacturing and selling prescription pharmaceutical products. It uses multiple drug delivery technologies to create a product pipeline for out-licensing to marketing partners. Its product brands include Flutiform, Foradil Certihaler, Paxil CR, Xatral OD, Solaraze, Triglide, Lodotra, Requip Once-a-day, Sular and ZYFLO CR. The Group's product pipelines are oral, inhalation, injectable, topical and solubilisation.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
